nodes	percent_of_prediction	percent_of_DWPC	metapath
Cinnarizine—DRD2—Dopamine receptors—DRD4—conduct disorder	0.107	0.107	CbGpPWpGaD
Cinnarizine—HRH4—Amine ligand-binding receptors—DRD4—conduct disorder	0.0513	0.0513	CbGpPWpGaD
Cinnarizine—DRD2—Nicotine Activity on Dopaminergic Neurons—DRD4—conduct disorder	0.0339	0.0339	CbGpPWpGaD
Cinnarizine—HRH4—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0335	0.0335	CbGpPWpGaD
Cinnarizine—HRH4—GPCRs, Other—DRD4—conduct disorder	0.0271	0.0271	CbGpPWpGaD
Cinnarizine—CYP1A2—Methylation—COMT—conduct disorder	0.0244	0.0244	CbGpPWpGaD
Cinnarizine—DRD2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0242	0.0242	CbGpPWpGaD
Cinnarizine—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.0239	0.0239	CbGpPWpGaD
Cinnarizine—DRD2—Monoamine GPCRs—DRD4—conduct disorder	0.0236	0.0236	CbGpPWpGaD
Cinnarizine—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.0232	0.0232	CbGpPWpGaD
Cinnarizine—DRD2—Amine ligand-binding receptors—DRD4—conduct disorder	0.0198	0.0198	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0195	0.0195	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.018	0.018	CbGpPWpGaD
Cinnarizine—HRH4—GPCRs, Other—HTR2A—conduct disorder	0.0177	0.0177	CbGpPWpGaD
Cinnarizine—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0162	0.0162	CbGpPWpGaD
Cinnarizine—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.0158	0.0158	CbGpPWpGaD
Cinnarizine—DRD2—Monoamine GPCRs—HTR2A—conduct disorder	0.0154	0.0154	CbGpPWpGaD
Cinnarizine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0153	0.0153	CbGpPWpGaD
Cinnarizine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.0151	0.0151	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—CGA—conduct disorder	0.0137	0.0137	CbGpPWpGaD
Cinnarizine—DRD2—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0129	0.0129	CbGpPWpGaD
Cinnarizine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0127	0.0127	CbGpPWpGaD
Cinnarizine—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.0127	0.0127	CbGpPWpGaD
Cinnarizine—HRH4—G alpha (i) signalling events—DRD4—conduct disorder	0.0127	0.0127	CbGpPWpGaD
Cinnarizine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0122	0.0122	CbGpPWpGaD
Cinnarizine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0103	0.0103	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0101	0.0101	CbGpPWpGaD
Cinnarizine—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00987	0.00987	CbGpPWpGaD
Cinnarizine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00796	0.00796	CbGpPWpGaD
Cinnarizine—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00794	0.00794	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—CGA—conduct disorder	0.00776	0.00776	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—DRD4—conduct disorder	0.00769	0.00769	CbGpPWpGaD
Cinnarizine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00735	0.00735	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—CGA—conduct disorder	0.00704	0.00704	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00697	0.00697	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00684	0.00684	CbGpPWpGaD
Cinnarizine—HRH4—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00658	0.00658	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—SLC6A4—conduct disorder	0.00591	0.00591	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—DRD4—conduct disorder	0.00556	0.00556	CbGpPWpGaD
Cinnarizine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00553	0.00553	CbGpPWpGaD
Cinnarizine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00549	0.00549	CbGpPWpGaD
Cinnarizine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.0054	0.0054	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—CGA—conduct disorder	0.0053	0.0053	CbGpPWpGaD
Cinnarizine—CYP2A6—Biological oxidations—COMT—conduct disorder	0.00528	0.00528	CbGpPWpGaD
Cinnarizine—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00524	0.00524	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.00521	0.00521	CbGpPWpGaD
Cinnarizine—HRH4—GPCR ligand binding—HTR2A—conduct disorder	0.00501	0.00501	CbGpPWpGaD
Cinnarizine—DRD2—G alpha (i) signalling events—DRD4—conduct disorder	0.00491	0.00491	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00485	0.00485	CbGpPWpGaD
Cinnarizine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00485	0.00485	CbGpPWpGaD
Cinnarizine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00469	0.00469	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00455	0.00455	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00447	0.00447	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—DRD4—conduct disorder	0.00434	0.00434	CbGpPWpGaD
Cinnarizine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00429	0.00429	CbGpPWpGaD
Cinnarizine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00426	0.00426	CbGpPWpGaD
Cinnarizine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00423	0.00423	CbGpPWpGaD
Cinnarizine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.0042	0.0042	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—CGA—conduct disorder	0.00416	0.00416	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—CGA—conduct disorder	0.00406	0.00406	CbGpPWpGaD
Cinnarizine—CACNA1I—Developmental Biology—EP300—conduct disorder	0.00401	0.00401	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—DRD4—conduct disorder	0.00394	0.00394	CbGpPWpGaD
Cinnarizine—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00393	0.00393	CbGpPWpGaD
Cinnarizine—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00391	0.00391	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.0039	0.0039	CbGpPWpGaD
Cinnarizine—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00388	0.00388	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00383	0.00383	CbGpPWpGaD
Cinnarizine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00377	0.00377	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—CGA—conduct disorder	0.00356	0.00356	CbGpPWpGaD
Cinnarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00337	0.00337	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00335	0.00335	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—WASF1—conduct disorder	0.00333	0.00333	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00309	0.00309	CbGpPWpGaD
Cinnarizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00309	0.00309	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.003	0.003	CbGpPWpGaD
Cinnarizine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.00297	0.00297	CbGpPWpGaD
Cinnarizine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Cinnarizine—CACNA1G—Developmental Biology—EP300—conduct disorder	0.00296	0.00296	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Cinnarizine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Cinnarizine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00294	0.00294	CbGpPWpGaD
Cinnarizine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Cinnarizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.00292	0.00292	CbGpPWpGaD
Cinnarizine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00291	0.00291	CbGpPWpGaD
Cinnarizine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.0029	0.0029	CbGpPWpGaD
Cinnarizine—CACNA1H—Developmental Biology—EP300—conduct disorder	0.00287	0.00287	CbGpPWpGaD
Cinnarizine—HRH4—GPCR downstream signaling—HTR2A—conduct disorder	0.00283	0.00283	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.00272	0.00272	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00267	0.00267	CbGpPWpGaD
Cinnarizine—HRH4—Signaling by GPCR—HTR2A—conduct disorder	0.00257	0.00257	CbGpPWpGaD
Cinnarizine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Cinnarizine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00251	0.00251	CbGpPWpGaD
Cinnarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.0025	0.0025	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.0025	0.0025	CbGpPWpGaD
Cinnarizine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00249	0.00249	CbGpPWpGaD
Cinnarizine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00247	0.00247	CbGpPWpGaD
Cinnarizine—CACNA1S—Developmental Biology—EP300—conduct disorder	0.00243	0.00243	CbGpPWpGaD
Cinnarizine—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00241	0.00241	CbGpPWpGaD
Cinnarizine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00236	0.00236	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—DRD4—conduct disorder	0.00233	0.00233	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00213	0.00213	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—CGA—conduct disorder	0.002	0.002	CbGpPWpGaD
Cinnarizine—CACNA1D—Developmental Biology—EP300—conduct disorder	0.00197	0.00197	CbGpPWpGaD
Cinnarizine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Cinnarizine—DRD2—Circadian rythm related genes—EP300—conduct disorder	0.00192	0.00192	CbGpPWpGaD
Cinnarizine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	0.0019	0.0019	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—COMT—conduct disorder	0.00183	0.00183	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—MAOA—conduct disorder	0.00182	0.00182	CbGpPWpGaD
Cinnarizine—CACNA1C—Developmental Biology—EP300—conduct disorder	0.00173	0.00173	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	0.00165	0.00165	CbGpPWpGaD
Cinnarizine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00163	0.00163	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—CGA—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—COMT—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—CGA—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—MAOA—conduct disorder	0.0016	0.0016	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—CGA—conduct disorder	0.00158	0.00158	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—DRD4—conduct disorder	0.00152	0.00152	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—HTR2A—conduct disorder	0.00152	0.00152	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—DRD4—conduct disorder	0.0015	0.0015	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—CGA—conduct disorder	0.00149	0.00149	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—WASF1—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—WASF1—conduct disorder	0.00127	0.00127	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—CGA—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—CGA—conduct disorder	0.00111	0.00111	CbGpPWpGaD
Cinnarizine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Cinnarizine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	0.00108	0.00108	CbGpPWpGaD
Cinnarizine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	0.000995	0.000995	CbGpPWpGaD
Cinnarizine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	0.000977	0.000977	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—CGA—conduct disorder	0.00095	0.00095	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—COMT—conduct disorder	0.000903	0.000903	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—DRD4—conduct disorder	0.000901	0.000901	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—MAOA—conduct disorder	0.000897	0.000897	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—DRD4—conduct disorder	0.000884	0.000884	CbGpPWpGaD
Cinnarizine—HRH4—Signaling Pathways—EP300—conduct disorder	0.000805	0.000805	CbGpPWpGaD
Cinnarizine—CACNA1D—Metabolism—EP300—conduct disorder	0.000785	0.000785	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—COMT—conduct disorder	0.000729	0.000729	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—MAOA—conduct disorder	0.000723	0.000723	CbGpPWpGaD
Cinnarizine—CACNA1C—Metabolism—EP300—conduct disorder	0.00069	0.00069	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—COMT—conduct disorder	0.000673	0.000673	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—MAOA—conduct disorder	0.000668	0.000668	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000648	0.000648	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—HTR2A—conduct disorder	0.000588	0.000588	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—HTR2A—conduct disorder	0.000577	0.000577	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—COMT—conduct disorder	0.000506	0.000506	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—MAOA—conduct disorder	0.000503	0.000503	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—COMT—conduct disorder	0.000502	0.000502	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—MAOA—conduct disorder	0.000498	0.000498	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000483	0.000483	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—COMT—conduct disorder	0.000429	0.000429	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—MAOA—conduct disorder	0.000426	0.000426	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000413	0.000413	CbGpPWpGaD
Cinnarizine—CYP2A6—Metabolism—EP300—conduct disorder	0.000387	0.000387	CbGpPWpGaD
Cinnarizine—CYP2B6—Metabolism—EP300—conduct disorder	0.000312	0.000312	CbGpPWpGaD
Cinnarizine—DRD2—Signaling Pathways—EP300—conduct disorder	0.000311	0.000311	CbGpPWpGaD
Cinnarizine—HRH1—Signaling Pathways—EP300—conduct disorder	0.000306	0.000306	CbGpPWpGaD
Cinnarizine—CYP1A1—Metabolism—EP300—conduct disorder	0.000289	0.000289	CbGpPWpGaD
Cinnarizine—CYP2D6—Metabolism—EP300—conduct disorder	0.000217	0.000217	CbGpPWpGaD
Cinnarizine—CYP2C9—Metabolism—EP300—conduct disorder	0.000215	0.000215	CbGpPWpGaD
Cinnarizine—CYP1A2—Metabolism—EP300—conduct disorder	0.000184	0.000184	CbGpPWpGaD
